Anti-herpetic properties of hydroalcoholic extracts and pressed juice from echinacea pallida

Planta Medica

Volumn 76, Issue 3, 2010, Pages 265-272

  Schneider, Sven ^a   Reichling, Jürgen ^a   Stintzing, Florian C ^b   Messerschmidt, Silke ^b   Meyer, Ulrich ^b   Schnitzler, Paul ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b WALA HEILMITTEL GMBH   (Germany)

Author keywords

Antiviral; Asteraceae; Echinacea pallida; Echinacea pressed juice; Herpes simplex virus; Hydroalcohoic extract

Indexed keywords

CAFFEIC ACID DERIVATIVE; ECHINACEA PALLIDA EXTRACT; FERULIC ACID;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; ECHINACEA; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MONKEY; NONHUMAN; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHINACEA; HAPLORHINI; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; PHYTOTHERAPY; PLANT PREPARATIONS; VIRUS REPLICATION;

ASTERACEAE; ECHINACEA (ASTERACEAE); ECHINACEA PALLIDA; HERPESVIRIDAE; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 77049098890     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1186137     Document Type: Article

References (24)

1. Chen Y, Scieux V, Garrait V, Socié G, Rocha V, Molina J M., Thouvenot D, Morfin F, Hocqueloux I, Garderei L, Esperou H, Selimi F, Dervergie A, Lelen G, Aymard M, Morinet F, Gluckman E, Ribaud P. Resistent herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. Clin Infect Dis 2000 31 927-935
2. De Clercq E. Antiviral drugs in current clinical use. J Clin Virol 2004 30 115-133
3. Bacon T H., Levin M J., Leary J J., Sarisky R T., Sutton D. Herpes simplex virus resistance to acyclovir and pencyclovir after two decades of antiviral therapy. Clin Microbiol Rev 2003 16 114-128
4. Koytchev R, Alken R G., Dundarov S. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis. Phytomedicine 1999 6 225-230
5. Carson C F., Ashton L, Dry L, Smith D W., Riley T V. Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. Antimicrob Agents Chemother 2001 48 450-451
6. Jassim S A., Naji M A. Novel antiviral agents: a medicinal plant perspective. J Appl Microbiol 2003 95 412-427
7. Barrett B. Medicinal properties of Echinacea: a critical review. Phytomedicine 2003 10 66-86
8. Woelkart K, Linde K, Bauer R. Echinacea for preventing and treating the common cold. Planta Med 2008 74 633-637
9. Goel V, Lovlin R, Chang C, Slama J V., Barton R, Gahler R, Bauer R, Goonewardene L, Basu T K. A proprietary extract from the Echinacea plant (Echinacea purpurea) enhances systemic immune responses during a common cold. Phytother Res 2005 19 689-694
10. Linde K, Barrett B, Woelkart K, Bauer R, Melchart D. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2006 (1) CD000530
11. Woelkart K, Bauer R. The role of alkamides as an active principle of Echinacea. Planta Med 2007 73 615-623
12. Zwickey H, Brush J, Iacullo C M., Connelly E, Gregory W L., Soumyanath A, Buresh R. The effect of Echinacea purpurea, Astralagus membranaceus and Glycyrrhiza glabra on CD25 expression in humans: a pilot study. Phytother Res 2007 21 1109-1112
13. Wacker A, Hilbig A. Virus inhibition by Echinacea purpurea. Planta Med 1978 33 89-102
14. Thompson K D. Antiviral activity of Viracea against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus. Antiviral Res 1998 39 55-61
15. Vimalanathan S, Kang L, Amiguet V T., Livesey J, Arnason J T., Hudson J. Echinacea purpurea aerial parts contain multiple antiviral compounds. Pharm Biol 2005 43 740-745
16. Hudson J, Vimalananthan S, Kang I, Amiguet V T., Livesey J, Amason J T. Characterization of antiviral activities in Echinacea root preparations. Pharm Biol 2005 43 790-796
17. Schnitzler P, Koch C, Reichling J. Susceptibility of drug-resistant clinical HSV-1 strains to essential oils of ginger, thyme, hyssop and sandalwood. Antimicrob Agents Chemother 2007 51 1859-1862
18. Reichling J, Koch C, Stahl-Biskup E, Sojka C, Schnitzler P. Virucidal activity of a -triketone-rich essential oil of Leptospermum scoparium (manuka oil) against HSV-1 and HSV-2 in cell culture. Planta Med 2005 71 1123-1127
19. Bauer R, Remiger P, Wagner H. Echinacea Vergleichende DC- und HPLC-Analyse der Herba-Drogen von Echinacea purpurea, E. pallida und E. angustifolia (3. Mitt.). Dtsch Apotheker Ztg 1988 128 174-180
20. Woelkart K, Dittrich P, Beubler E, Pini F, Schoop R, Suter A, Bauer R. Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans. Planta Med 2008 74 651-656
21. Woelkart K, Marth E, Suter A, Schoop R, Raggam R, Koidl C, Kleinhappl B, Bauer R. Bioavailability and pharmacokinetic studies on Echinacea purpurea preparations and their interaction with the immune system. Int J Clin Pharm Ther 2006 44 401-408
22. Barnes J, Anderson L A., Gibbons S, Phillipson J D. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol 2005 57 929-954
23. Binns S E., Hudson J, Merali S, Arnason J T. Antiviral activity of characterized extracts from Echinacea spp. (Heliantheae: Asteraceae) against herpes simplex virus (HSV-1). Planta Med 2002 68 780-783
24. Bodinet C, Beuscher N. Antiviral and immunological activity of glycoproteins from Echinacea purpurea Radix. Planta Med 1991 57 (Suppl.2) A33